Ying Huang

Preclinical Safety Evaluation of Biopharmaceuticals

M. Serabian, Ying Huang, 2010 .

Ethnic pharmacokinetic comparison of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler (BGF MDI) between Asian and Western healthy subjects.

P. Dorinsky, P. Assam, Ying Huang, 2020, Pulmonary pharmacology & therapeutics.

The importance of including topics related to pharmacogenetics, pharmacogenomics, and medical genetics in the pharmacy curriculum.

O. Aruoma, M. Moridani, Ying Huang, 2009, American journal of pharmaceutical education.

Regulation of Adenoviral Vector-Based Therapies: An FDA Perspective

Ying Huang, I. Irony, Mike Havert, 2016 .

Evolving drug regulatory landscape in China: A clinical pharmacology perspective

Diansong Zhou, Ying Huang, Xiaoying Zhao, 2021, Clinical and translational science.

Preclinical Safety Evaluation of Biopharmaceuticals

M. Serabian, Ying Huang, 2010 .

The FDA Review Process for Cancer Gene Therapy

Ying Huang, A. Byrnes, K. Shannon, 2014 .